METTL3 and posterior cortical atrophy: In agreement with a number of other studies in distinct PCa cohorts (Ji et al., 2020; Li B. et al., 2020; Yuan et al., 2020; Haigh et al., 2022), METTL3 expression was significantly higher in PCa compared with non-malignant prostate tissue in the current study.